MustGrow Reports Significant U.S. Potato Yield and Economic Performance in Large Scale Field Trials Utilizing TerraSante(TM)
MWN-AI** Summary
MustGrow Biologics Corp. has announced impressive results from large-scale field trials of its organic biofertilizer, TerraSante™, focusing on potato farming in Washington State and Idaho. This eco-friendly product, derived from mustard, aims to enhance crop yields, soil health, and nutrient and water use efficiencies. The trials demonstrated a marked increase in potato yields, with farmers reporting a 2-ton increase per acre, resulting in an estimated value boost of approximately $5,000 per acre. This was achieved at a cost of only $180 per acre for the TerraSante™ application.
The trials revealed significant improvements not just in yield but also in potato quality and size, translating into fewer 'culls' or unsellable potatoes. TerraSante™ is recognized under US organic certification programs and is currently available in several states including California, Florida, and Arizona. The results align with earlier small plot tests that MustGrow had conducted, confirming the efficacy of TerraSante™ in promoting substantial yield increases—up to 39.2% in some applications compared to untreated plots.
Beyond boosting potato crop performance, the organic biofertilizer contributes positively to soil health by enhancing microbial activity and nutrient availability, crucial for sustainable agricultural practices. MustGrow's commitment to regenerative agriculture positions it well in a market increasingly focused on environmentally-friendly farming solutions. The company's ongoing collaboration with agricultural firms like Bayer AG and its portfolio of patents underscore its innovative approach to fulfilling the growing demand for sustainable crop inputs.
MWN-AI** Analysis
MustGrow Biologics Corp. (TSXV: MGRO) has recently reported impressive results from the large-scale trials of its organic biofertilizer, TerraSanteTM, specifically in potato farming in the U.S. The advantage of a US$5,000 increase in value per acre, coupled with a significant boost in yield and quality, positions MustGrow as a favorable investment in the agricultural sector, particularly for those focusing on sustainable practices.
The findings indicate that at a reasonable application cost of US$180 per acre, TerraSanteTM delivers a considerable yield enhancement, with gains ranging from 4.08 to 6.20 tons per acre compared to untreated crops. This level of profitability is compelling in a market where agriculture is increasingly scrutinized for its environmental footprint, presenting an opportunity for MustGrow to capitalize on the rising demand for sustainable agriculture solutions.
The broader agricultural landscape in North America is trending towards eco-friendly alternatives as synthetic fertilizers face regulatory pressures. MustGrow's commitment to acting as a solution provider with innovative, patented technologies positions it well to capture market share in this evolving scenario. Additionally, the robust customer performance data reinforces the credibility of TerraSante as a reliable option for increasing crop yield while promoting soil health.
Investors should watch for MustGrow's expansion initiatives in other states, as the successful trials pave the way for potential scaling. The company’s strategic focus on relevant markets like California, Florida, and other major agricultural states indicates the potential for sustained growth and increasing shareholder value.
In light of these promising developments, MustGrow represents a compelling opportunity for investors interested in the agricultural sector, particularly those prioritizing sustainability and regenerative practices. The company's robust positioning, supported by strong yield results, suggests that it may yield favorable returns in the upcoming agricultural cycles.
**MWN-AI Summary and Analysis is based on asking OpenAI to summarize and analyze this news release.
- Mustard-derived organic TerraSanteTM focuses on crop yields, soil and soil microbiome health, and nutrient/water use efficiencies;
- Large scale field trial showed 2 ton per acre yield increase with larger size potatoes and less culls equating to approximately US$5,000 increase in value per acre; and
- Significant soil health benefit when applied in combination with the current grower standard program.
Saskatoon, Saskatchewan--(Newsfile Corp. - December 10, 2025) - MustGrow Biologics Corp. (TSXV: MGRO) (OTCQB: MGROF) (FSE: 0C0) (the "Company" or "MustGrow"), a leading provider of biological and regenerative agriculture solutions, is pleased to announce outstanding performance metrics on its organic TerraSanteTM biofertility product applied to potato farming acres in Washington State and Idaho, based on customer performance data.
In its use by a Washington State farming customer, TerraSanteTM demonstrated a consistent and substantial potato yield, size, and quality increase at a dose rate of 11 lbs/acre. This customer performance data was generated on a large-scale commercial potato field. With the increase in size, quality and yield, the farmer estimated an approximate US$5,000 increase in value per acre at a cost of only US$180 per acre for TerraSanteTM. Work done in fields in Idaho has also shown significant benefits to the soil and health of the potato crops when used within a currently established grower production program.
These large-scale field trial results are consistent with small plot results that MustGrow has completed in the U.S. with TerraSanteTM, as outlined in the following table:
| Treatment | TerraSanteTM Application | Total Yield (lbs/ac) | Total Yield (ton/ac) | Increase vs. Untreated (lbs) | Increase vs Untreated (ton) | % Increase |
| Untreated (Check) | n/a | 34,836 | 15.80 | - | - | - |
| TerraSanteTM | 15 lbs/ac | 44,468 | 20.16 | 9,632 | 4.37 t | 27.6% |
| TerraSanteTM | 20 lbs/ac | 43,838 | 19.88 | 9,002 | 4.08 t | 25.8% |
| TerraSanteTM | 50 lbs/ac | 48,497 | 22.00 | 13,661 | 6.20 t | 39.2% |
The following figures illustrate TerraSanteTM 'wet-able' powder being mixed into liquid format and applied through typical spray equipment.
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7108/277510_b03538808441cb34_001full.jpg
To view an enhanced version of this graphic, please visit:
https://images.newsfilecorp.com/files/7108/277510_b03538808441cb34_002full.jpg
MustGrow's mustard-derived TerraSanteTM organic biofertilizer is a soluble mixable form containing nutritious plant proteins and carbohydrates that feed the soil and soil microbes. TerraSanteTM is currently registered and approved for sale in California, Florida, Arizona, Idaho, Oregon, and Washington State, under Organic OMRI Listed® certification and California's Organic Input Material (OIM) Program.
In 2024, the United States Department of Agriculture (USDA) reported 927,000 potato acres harvested for US$4.6 billion of value sold.(1)
TerraSanteTM for Soil and Ecological Health
MustGrow's biofertility program focuses on soil and soil microbiome health, nutrient and water use efficiencies, and plant yields. Soil is a farmer's most valuable asset, and MustGrow's mustard plant-based technologies are being applied with the intention to improve not only the health of the soil, but also the surrounding ecological environment.
TerraSanteTM, an organic biofertilizer in soluble mixable form, contains nutritious plant proteins and carbohydrates that feed the soil and soil microbes, potentially improving beneficial microbial activity and ensuring long-term sustainable soil health. These targeted micro-communities have been shown to work to improve nutrient availability, which can potentially increase plant vigor and yields, while reducing plant stress. TerraSanteTM has the potential to improve crop nutrient uptake and, hence, overall crop performance. There are no artificial additives or preservatives used during its manufacturing.
To learn more about TerraSanteTM, visit TerraSanteTM - MustGrow.
Notes:
1) Potatoes 2024 Summary 09/26/2025
About MustGrow
MustGrow Biologics Corp. is a fully integrated provider of innovative biological and regenerative agriculture solutions designed to support sustainable farming. The Company's proprietary and third-party product lines offer eco-friendly alternatives to restricted or banned synthetic chemicals and fertilizers. In North America, MustGrow offers a portfolio of third-party crop nutrition solutions, including micronutrients, nitrogen stabilizers, biostimulants, adjuvants and foliar products. These products are synergistically distributed alongside MustGrow's wholly-owned proprietary products and technologies that are derived from mustard and developed into organic biocontrol and biofertility products to help replace banned or restricted synthetic chemicals and fertilizers. Outside of North America, MustGrow is focused on collaborating with agriculture companies, such as Bayer AG in Europe, the Middle East and Africa, to commercialize MustGrow's wholly-owned proprietary products and technologies. The Company is dedicated to driving shareholder value through the commercialization and expansion of its intellectual property portfolio of approximately 110 patents that are currently issued and pending, and the sales and distribution of its proprietary and third-party product lines through NexusBioAg. MustGrow is a publicly traded company (TSXV-MGRO) and has approximately 58.9 million common shares issued and outstanding and 69.1 million shares fully diluted. For further details, please visit www.mustgrow.ca.
Contact Information
Corey Giasson
Director & CEO
Phone: +1-306-668-2652
info@mustgrow.ca
MustGrow's Forward-Looking Statements
Certain statements included in this news release constitute "forward-looking statements" which involve known and unknown risks, uncertainties and other factors that may affect the results, performance or achievements of MustGrow.
Generally, forward-looking information can be identified by the use of forward-looking terminology such as "plans", "expects", "is expected", "budget", "estimates", "intends", "anticipates" or "does not anticipate", or "believes", or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might", "occur" or "be achieved". Forward-looking statements in this news release, including statements about: the impact and significance of customer performance data and field testing, the increase in value of yields and the costs of such increase in value, if any, and are subject to a number of risks and uncertainties that may cause the actual results of MustGrow to differ materially from those discussed in such forward-looking statements, and even if such actual results are realized or substantially realized, there can be no assurance that they will have the expected consequences to, or effects on, MustGrow. Important factors that could cause MustGrow's actual results and financial condition to differ materially from those indicated in the forward-looking statements include: those risks described in more detail in MustGrow's Annual Information Form for the year ended December 31, 2024 and other continuous disclosure documents filed by MustGrow with the applicable securities regulatory authorities which are available on SEDAR+ at www.sedarplus.ca. Readers are referred to such documents for more detailed information about MustGrow, which is subject to the qualifications, assumptions and notes set forth therein.
Neither the TSX Venture Exchange, nor their Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange), nor the OTC Markets has approved the contents of this release or accepts responsibility for the adequacy or accuracy of this release.
© 2025 MustGrow Biologics Corp. All rights reserved.
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/277510
FAQ**
How does MustGrow Biologics Corp. plan to scale the adoption of TerraSanteTM among potato farmers in regions beyond Washington State and Idaho, especially considering its potential market size in other U.S. agricultural sectors?
What specific metrics does MustGrow use to evaluate long-term soil health benefits when applying TerraSanteTM, and how do these metrics correlate to the improved crop yields reported in large-scale field trials?
Given the approximately US$5,000 increase in value per acre reported by farmers using TerraSanteTM, what are the expected profit margins for MustGrow Biologics Corp. when factoring in production and distribution costs for TerraSanteTM?
Can MustGrow provide insights into potential partnerships for commercialization and market expansion, particularly plans involving Bayer AG and the impact on TerraSanteTM's reach in markets outside North America?
**MWN-AI FAQ is based on asking OpenAI questions about Mustgrow Biologics Corp. - Common Shares (CNQC: MGRO:CC).
NASDAQ: MGRO:CC
MGRO:CC Trading
-0.32% G/L:
$3.10 Last:
26,903 Volume:
$3.07 Open:
